CLINICAL RESEARCH STUDY
COVID-19 Treatment Study
A Clinical Research Study Evaluating an Investigational Oral Antiviral for High-Risk Adults
We are enrolling adults who have recently tested positive for COVID-19 and may be at higher risk for severe illness. This study is evaluating an investigational oral medication to determine if it can help prevent symptoms from becoming more serious.
Time is critical — contact us as soon as possible after a positive COVID-19 test to see if you may qualify.
Study overview
PURPOSE
To determine whether Mirena can return the uterine lining to normal after 6 months of treatment.
TREATMENT
Oral medication taken at home, designed to help stop the virus from multiplying in the body.
STUDY DESIGN
- Phase 3, randomized, double-blind, placebo-controlled study
- Participants receive either study medication or placebo
- Neither participants nor study staff know which treatment is assigned
PARTICIPATION INCLUDES
- Screening and enrollment shortly after a positive COVID-19 test
- Study medication taken as directed
- Follow-up visits or check-ins to monitor symptoms and recovery
Who may qualify
- Age 18 or older
- Recently tested positive for COVID-19
- Not currently hospitalized
- Have certain health conditions or risk factors that increase the chance of severe illness
- Meet additional study criteria
Why Participate
- Access to an investigational treatment at no cost
- Close monitoring by experienced medical professionals
- Opportunity to contribute to research that may improve COVID-19 treatment options
Contact us as soon as possible after a positive COVID-19 test — enrollment timing is critical for this study.
COMPENSATION
Up to $1,100
Or more if you qualify for the study